ACA
Avoro Capital Advisors Portfolio holdings
AUM
$5.71B
This Quarter Return
+55.54%
1 Year Return
+11.37%
3 Year Return
+255.37%
5 Year Return
+558.9%
10 Year Return
+18,722.72%
AUM
$7.04B
AUM Growth
+$7.04B
(+39%)
Cap. Flow
+$374M
Cap. Flow
% of AUM
5.32%
Top 10 Holdings %
Top 10 Hldgs %
74.64%
Holding
53
New
9
Increased
20
Reduced
11
Closed
7
Top Buys
| 1 |
ARNA
Arena Pharmaceuticals Inc
ARNA
|
$161M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$128M |
| 3 |
Madrigal Pharmaceuticals
MDGL
|
$64.1M |
| 4 |
PMV Pharmaceuticals
PMVP
|
$57.6M |
| 5 |
Kura Oncology
KURA
|
$42.4M |
Top Sells
| 1 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$115M |
| 2 |
Allogene Therapeutics
ALLO
|
$48.3M |
| 3 |
Iovance Biotherapeutics
IOVA
|
$27.2M |
| 4 |
Aurinia Pharmaceuticals
AUPH
|
$27.1M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
$24.7M |
Sector Composition
| 1 | Healthcare | 66.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ISEE
26
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $40.9M | 0.58% |
7,250,000
+150,000
| +2% | +$846K |
|
|
ATNX
27
DELISTED
Athenex, Inc. Common Stock
ATNX
| $39.5M | 0.56% |
3,265,000
-585,000
| -15% | -$7.08M |
|
|
MRNS
28
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $38.6M | 0.55% |
3,000,000
-8,960,000
| -75% | -$115M |
|
29
Xenon Pharmaceuticals
XENE
$2.99B
| $31M | 0.44% |
2,800,000
| – | – |
|
30
Cue Biopharma
CUE
$62M
| $28.1M | 0.4% |
1,870,000
| – | – |
|
31
Altimmune
ALT
$324M
| $26.4M | 0.38% |
+2,000,000
| New | +$26.4M |
|
|
AMRN
32
Amarin Corp
AMRN
$314M
| $25.3M | 0.36% |
6,000,000
+4,000,000
| +200% | +$16.8M |
|
33
Travere Therapeutics
TVTX
$1.69B
| $24.5M | 0.35% |
1,325,000
+275,000
| +26% | +$5.08M |
|
34
Relay Therapeutics
RLAY
$676M
| $21.3M | 0.3% |
+500,000
| New | +$21.3M |
|
|
AVDL
35
Avadel Pharmaceuticals
AVDL
$1.4B
| $21.2M | 0.3% |
4,200,000
-365,655
| -8% | -$1.84M |
|
36
RAPT Therapeutics
RAPT
$190M
| $18.5M | 0.26% |
+575,000
| New | +$18.5M |
|
37
Black Diamond Therapeutics
BDTX
$162M
| $18.2M | 0.26% |
602,500
+77,500
| +15% | +$2.34M |
|
|
ZGNX
38
DELISTED
Zogenix, Inc.
ZGNX
| $15.7M | 0.22% |
875,000
-1,375,000
| -61% | -$24.7M |
|
39
Avidity Biosciences
RNA
$6B
| $15.3M | 0.22% |
545,000
-40,000
| -7% | -$1.13M |
|
|
PNT
40
DELISTED
POINT Biopharma Global Inc. Common Stock
PNT
| $14.4M | 0.2% |
+1,000,000
| New | +$14.4M |
|
|
GNCA
41
DELISTED
Genocea Biosciences, Inc.
GNCA
| $11.6M | 0.17% |
+5,084,184
| New | +$11.6M |
|
|
ITOS
42
DELISTED
iTeos Therapeutics
ITOS
| $11.3M | 0.16% |
+460,000
| New | +$11.3M |
|
43
Fennec Pharmaceuticals
FENC
$244M
| $10.1M | 0.14% |
1,670,000
| – | – |
|
44
Tango Therapeutics
TNGX
$718M
| $8.67M | 0.12% |
+800,000
| New | +$8.67M |
|
|
ALIM
45
DELISTED
Alimera Sciences, Inc.
ALIM
| $2.02M | 0.03% |
415,999
| – | – |
|
46
Kymera Therapeutics
KYMR
$2.99B
| $1.6M | 0.02% |
+49,400
| New | +$1.6M |
|
|
47
Allogene Therapeutics
ALLO
$246M
| – | – |
-1,128,594
| Closed | -$48.3M |
|
|
48
Aurinia Pharmaceuticals
AUPH
$1.54B
| – | – |
-1,670,000
| Closed | -$27.1M |
|
49
Cardiff Oncology
CRDF
$128M
| – | – |
-1,000,000
| Closed | -$5.01M |
|
50
PTC Therapeutics
PTCT
$4.34B
| – | – |
-324,750
| Closed | -$16.5M |
|